Scientific Validation Of Polydextrose As A Fibre AndGeoffreyOsullivan
Presents an overview of the scientific evidence and methods used to prove polydextrose is a safe and effective soluble prebiotic fibre with high toleration
Scientific Validation Of Polydextrose As A Fibre AndGeoffreyOsullivan
Presents an overview of the scientific evidence and methods used to prove polydextrose is a safe and effective soluble prebiotic fibre with high toleration
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...IFSMED
Rheumatologist Dr. Alex Shikhman makes the connection between ankylosing spondylitis and the gut. Offering natural dietary supplements to help manage many of the side effects associated with the disease
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gianfranco Tammaro
PROF. ANTONIO GASBARRINI - 3° Giornata Master ECM in Gastroenterologia 2016 (25/11/2016) - Fondazione Santa Lucia - Sala Congressi - Roma
Sito: www.asmad.net
Canale Youtube: https://youtu.be/ouYcXg_ZtJM
Probiotics in diarrhea in India - Special Ref to LrGG Lactobacillus Rhamnosus...Gaurav Gupta
Probiotics in diarrhea in India - Special Ref to LrGG Lactobacillus Rhamnosus GG - june 2018 unobiotic, superflora GG,
Talk taken in Chandigarh in June 2018
Probiotics are live microorganisms that confer health benefits when colonize the gastrointestinal tract. The various microbial strains are now found to provide therapeutic effects through the metabolites they produce, digestion of dietary fibers, inhibition of pathogen adhesion, provide missing enzyme, maintaining homeostasis and also controlling brain activities which may lead to autism if disturbed.
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...IFSMED
Rheumatologist Dr. Alex Shikhman makes the connection between ankylosing spondylitis and the gut. Offering natural dietary supplements to help manage many of the side effects associated with the disease
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gianfranco Tammaro
PROF. ANTONIO GASBARRINI - 3° Giornata Master ECM in Gastroenterologia 2016 (25/11/2016) - Fondazione Santa Lucia - Sala Congressi - Roma
Sito: www.asmad.net
Canale Youtube: https://youtu.be/ouYcXg_ZtJM
Probiotics in diarrhea in India - Special Ref to LrGG Lactobacillus Rhamnosus...Gaurav Gupta
Probiotics in diarrhea in India - Special Ref to LrGG Lactobacillus Rhamnosus GG - june 2018 unobiotic, superflora GG,
Talk taken in Chandigarh in June 2018
Probiotics are live microorganisms that confer health benefits when colonize the gastrointestinal tract. The various microbial strains are now found to provide therapeutic effects through the metabolites they produce, digestion of dietary fibers, inhibition of pathogen adhesion, provide missing enzyme, maintaining homeostasis and also controlling brain activities which may lead to autism if disturbed.
Clinical examinations demonstrated that many probiotic strains (Lactic Acid Bacteria (LAB)) can inhibit Helicobacter pylori infection so that when patients were treated with probiotics, Helicobacter pylori were diminished. So probiotics used as helpful in the treating of Helicobacter pylori infection. Various studies support the hypothesis that probiotics inhibit Helicobacter pylori growth owing to the production of short-chain fatty acids (SCFAs) and/or bacteriocins. These studies have been carried out mostly in vitro. High lactic acid-producer strains of Lactobacillus were shown to decrease Helicobacter pylori density in the stomach. The release of bacteriocins active against Helicobacterpylori has been studied chiefly in Lactobacillus. The supernatant of a culture of Lactobacillus acidophilus was shown to inhibit both the urease activity and growth of Helicobacter pylori free or adherent to epithelial cells. The properties of LAB, decreasing the luminal pH through the creation of unpredictable short chain unsaturated fats (SCFA) like acidic, lactic or propionic corrosive. Rendering particular supplements inaccessible to pathogens, decreasing the redox capability of the luminal condition, producing hydrogen peroxide under anaerobic conditions and/or creating particular inhibitory mixes like bacteriocins.
If you find your digestive tract grumbling and protesting more than you think it should, you might want to replenish your gut’s probiotics. Probiotics are a combination of living, beneficial bacteria that occur naturally in the human intestinal tract. Probiotics are essential for maintaining healthy digestion.
Microbiota intestinale e Patologie NeurodegenerativeASMaD
Presentazione a cura del Professor Giovanni Gasbarrini - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
Probiotics for Women with Organic Prebiotics.pdfTuragHost1
he use of Probiotics is used as "Complimentary and Alternative Medicine" (CAM). The Probiotics are mostly used to treat conditions such as inflammatory bowel diseases, Crohn's disease, infectious diarrhea and stomach ulcers that are caused by the bacterium Heliocobacter Pylori, (H.pylori). These are just a few of the conditions that are favorably affected by Probiotics. They also react favorably for those who are lactose intolerant, suffer from gas buildup, bloating, and have diarrhea caused by the rotavirus
What do probiotics do in our bodies?
Probiotics can help to regulate our gut flora which can, in turn, assist in digestion, vitamin production, providing structural integrity to the gut lining barrier, protection against pathogens, and serve as a communication centre. Our gut microbiome, therefore, plays a pivotal role in the regulation of metabolic, immune and endocrine functions and can have far reaching effects on our health.
Digestive
An imbalance in our gut flora, or “dysbiosis” can lead to several IBS symptoms such as diarrheoa, constipation, and abdominal pain, for which probiotics can be safe and effective at relieving through balancing our gut bacteria. They have also been successfully used in preventing antibiotic-associated diarrheoa.
Immune
Probiotics also work by modulating the immune system, which is unsurprising when you consider that more than 70% of immune cells are located in the gut. Probiotic bacteria such as Lactobacilli and Bifidobacteria, trigger different effects on the immune system, from stimulation of gut immunity at local level: producing local, first line immune molecules like secretory IgA, to systemic responses, lowering the levels of inflammatory molecules.
Cardiovascular - by lowering inflammatory molecules such as C-reactive protein (CRP), probiotics could also contribute to protection against cardiovascular events. Accumulating evidence shows probiotics have the ability to lower LDL-cholesterol and improve the LDL/HDL ratio, as well as lowering blood pressure, blood glucose levels and body mass index – and thus may provide several cardiovascular health benefits.
Skin
Conditions such as acne are thought to be associated with the specific bacterial strain Propionibacterium acnes. This bacteria is found naturally on the skin and can become an opportunistic pathogen (in overgrowth) when conditions are out of balance – and because the gut and skin microbiomes are closely linked, supporting your gut health with a probiotic could help support healthy skin. Multiple studies have also linked probiotics to an improvement in the severity of eczema symptoms.
Mood
There are strong correlations between the gut microbiome and brain health, and probiotic supplements have been shown to improve symptoms of depression. A deficiency in serotonin, the key neurotransmitter responsible for regulating mood, can contribute to depression and anxiety.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
2. 2
Table of Contents
Prebiotics and Probiotics in persons with IBD ..............................Error! Bookmark not defined.
Introduction..................................................................................................................................... 3
Pro, Pre and antibiotics in the management of Inflammatory Bowel Disease................................ 3
Prevention of Inflammatory Bowel Disease ................................................................................... 4
Symptoms of Inflammatory Bowels Disease.................................................................................. 4
Roles of Probiotics.......................................................................................................................... 4
Lactobacillus ............................................................................................................................... 4
Escherichia coli Nissle 1917 ...................................................................................................... 5
Saccharomyces boulardii............................................................................................................. 5
The Microflora ............................................................................................................................ 6
The roles of Microflora in Inflammatory Bowel Disease ............................................................... 7
Roles of Prebiotics .......................................................................................................................... 7
Lactulose ..................................................................................................................................... 8
Lactosucrose................................................................................................................................ 8
Oligofructose and inulin.............................................................................................................. 8
Treatment of Inflammatory Bowel Disease .................................................................................... 9
Conclusion ...................................................................................................................................... 9
References..................................................................................................................................... 10
3. 3
Prebiotics and Probiotics in persons with IBD
Introduction
A significant research body nowadays exists investigating the role of prebiotics and
probiotics in improving chronic abdominal inflammation. The essay will give an overview of the
use of prebiotics and probiotics in human IBD, prevention and treatment of Inflammatory Bowel
Disease. Inflammatory bowel disease (IBD) comprises of two distinct clinical forms, Crohn’s
disease (CD) and Ulcerative Colitis (UC) (Berg, Clemente, and Colombel, 2015, p.795) with an
unidentified etiology that nonetheless are considered to share nearly undistinguishable
pathophysiological circumstances. Existing reviews summarize the factors perpetuating and
initiating Inflammatory bowel disease, from four essential perspectives: microbial flora role,
barrier dysregulation, immune dysregulation, and genetics. The interaction of the intestinal
microorganisms with the mucosal milieu (Berg, Clemente, and Colombel, 2015, p.795), in
vulnerable individuals, activates a cascade of reactions which begin with the relations of the
microorganisms and their constituents. These also comprise the dendritic cells intestinal
epithelial cells through receptors, followed by interactions of antigen-presenting cells along with
the lymphocytes, mucosal lymphocytes and vascular endothelial cells, granulocytes, and
lymphocytes, producing inflammatory intermediaries and leading to mucosal damages (Utrilla et
al., 2015, p.819). With this in mind, the investigation is ongoing in these arenas, with the final
aim of producing new therapies (Vogt et al.,2016, p.13537). No specific microbe has been
attested to cause Inflammatory Bowel Disease, notwithstanding that various microbes have been
examined as incriminating factors in the aetiopathogenesis of Inflammatory Bowel Disease.
These comprise bacteria, Escherichia coli, Chlamydia pneumonia, Listeria monocytogenes, and
Mycobacterium paratuberculosis, and cytomegalovirus, however, none of the above-said has
been connected directly with the process (Leung, Rivera, Furness, and Angus, 2016, p.421).
Nowadays further attention is paid to the lively balance between intestinal bacteria, specifically
commensal flora along with the host defense mechanism at the intestinal mucosa, as well as their
roles in the maintenance and initiation of intestinal inflammation. There is substantial proof that
deviations in the bowel microbes’ flora owing to conservational or diet dynamics are of
overriding prominence in the IBD pathogenesis. Additionally, the roles of microflora in intestinal
complaints is supported by findings that probiotics can enhance Inflammatory Bowel Disease or
antibiotics’ use could profit specific subsets of Inflammatory Bowel Disease patients. The
information has led to new beneficial strategies which target the microflora of patients with
Inflammatory Bowel Disease using synbiotics, prebiotics, probiotics agents, ranging from simple
carbohydrates to hereditarily engineered microbes with the roles of screening immunoregulatory
cytokines (Capitán‐ Cañadas et al., 1110).
Pro, Pre and antibiotics in the management of Inflammatory Bowel Disease
The accruing acquaintance that microbiota moderates gut immunological and physiology
function in Inflammatory Bowel Disease, aforementioned, has led experts to explore the
efficiency of probiotics, synbiotics, and prebiotics in the management of Inflammatory Bowel
Disease. This healing approach aims at restoring the poise of the gastrointestinal microflora to
lessen or prevent intestinal irritation. Numerous microbial strains, carbohydrates combinations,
4. 4
and their amalgamations have been tested in experimental models and scientific trials, along with
the healing manipulation of bowel microbiota.
Prevention of Inflammatory Bowel Disease
IBD is amongst the most predominant enduring gastrointestinal conditions in U.S. with a
general healthcare cost of 1.8 billion. Inflammatory Bowel Disease has no cure and patients
usually require a lifespan of care; hence effective measures to lessen hospitalization, morbidity
and surgery are precarious to improving disease free reduction and eminence of life. Research
has shown that IBD patient does not obtain preventive services with the similar care as others.
Having proper diet such as low fat foods, unprocessed and fresh foods has been proved to
prevent the occurrence of the disease. Further, one needs to be stress-free as this will help
preventing the IBD.
Symptoms of Inflammatory Bowels Disease
The symptoms of IBD mostly occur in relation to how much and where it is inflamed.
The symptoms may include vomiting, nausea, fatigue and lethargy, Diarrhoea, abnormal pain,
weight loss and passing of fresh blood in the stool. Other symptoms may include headache,
blurred vision and mouth ulcers.
Roles of Probiotics
These are living microorganisms, capable of surviving stomach acid along with the bile,
maintains viability all through the extended storage periods, and safe for human ingestion,
inducing valuable outcomes in the hosts. Numerous mechanisms of actions of probiotics relative
to treatment and prevention of Inflammatory Bowel Disease have been described, such as
antimicrobial activities and dominance of microbial development, initiation, and
immunomodulation of immune responses (Konturek, 2015, p.491), improvement of barricade
activities, as well as subdual of human T-cell propagation. Probiotics have similarly been found
to trigger their influence by using DNA as has had been displayed by an experiment using
probiotic Deoxyribonucleic acid. Derived initially from refined food, mainly dairy products, this
group comprises E. coli Nissle, Bifidobacterium species 1917and Lactobacillus species, C.
butyricum, Lactococcus lactis, VSL#3, and Saccharomyces boulardii hereditarily engineered to
discharge IL-10. An exciting new technique to what could plea a probiotic is helminths.
Lactobacillus
Lactobacilli have been utilized in several investigational models as well as clinical
experiments to scrutinize their influence on gut pathophysiology. In investigational models,
several Lactobacillus strains induce differential regulation of several genes involved in
indispensable physiological purposes such as immune reactions and weaken damage to the colon
by methotrexate and acetic acid (Laval et al., p.9). Lactobacillus casei hinders IL-6 production
within LPS-stimulated outsized intestinal lamina propria mononuclear cells and downregulates
nuclear NF-Κb translocation in in SAMP1 or Yit mice. Numerous Lactobacillus strains
upregulate intestinal MUC3 mRNA appearance (Konturek, 2015, p.491). Lactobacillus
rhamnosus was found to evoke cyclooxygenase-2 expression in human T84 colon epithelial cells
5. 5
as well as Lactobacillus paracasei ssp. paracasei ssp. paracasei overrides human T-cell
propagation (van Baarlen, Wells, and Kleerebezem, 2013, p.215). Lactobacillus GG advances
intestinal purpose by hindering of apoptosis of intestinal epithelial cells, averts colitis recurrence
in HLA-B27 transgenic rats following antibiotic management and weakens TNBS-evoked
colitis. Benefits have been shown with oral management of Lactobacillus
salivarius spp. salivarius CECT5713 within TNBS-evoked colitis. Dextran sulphate sodium
evoked colitis was weakened by everyday management of Lactobacillus GG, Lactobacillus
plantarum and Lactobacillus crispatus in several models of animals. In IL-10 knock-out pests,
Lactobacillus plantarum and Lactobacillus salivarius ssp. salivariusUCC118 have been revealed
to lessen intestinal irritation (Deriu et al.,2013, p.26).
Escherichia coli Nissle 1917
The probiotic Nissle 1917 (EcN) is a strain of E. coli that has been applied for years in
Central Europe for the prevention and management of intestinal complaints (Dupont, 2014,
p.1042). In trial condition, the E. coli Nissle 1917 downregulated the development of newly
enlisted T cells into the mucosa and confines intestinal irritation through TLR -4 and TLR-2
alleyways. DSS-evoked colitis in pests is averted by management of soluble microbial antigens
from E. coli strain nonpathogenic. Currently, Zyrek showed in vitro that EcN restored the
interrupted epithelial barriers within the colonic epithelial cell lines T84. In dual clinical
experiments E. coli Nissle 1917 was found correspondent to mesalamine at accomplishing and
maintaining UC remission for twelve-months (Kashyap et al., 2013, p.977). In preservation of
CD remission, no difference was realized in decrease between placebo and E. coli Nissle 1917,
however it should be considered that there is sturdy proof for the influence of E. coli Nissle 1917
in preservation of diminution of UC (Deriu et al.,2013, p.26).
Saccharomyces boulardii
Saccharomyces boulardii is a nonpathogenic yeast applied for management of diarrhea.
The yeast was presently shown to weaken the migration of T-helper 1 cell into the mucosa
(DuPont, 2014, p.1042), changing the cytokines’ cascades, as well as producing low-molecular-
mass element blocking NF-Κb instigation as well as IL-8 countenance. S. boulardii combination
with mesalamine was found to trigger important CD remission prolongation as well as to have
some effective outcomes in patient with active UC (Dupont, 2014, p.1042).
Clostridium butyricum
Clostridium butyricum an enterobacterium, produces in height levels of short fatty acid
that has been described to be significant in intestinal physiology. Dual studies have reported in
rodents to scrutinize the effect of this microbe. Indeed, a C. butyricum imitative was
experimented in DSS-colitis models effectively whereas Okamoto did a research on M588 strain
then demonstrated that it weakened intestinal irritation and proposed that oral C.
butyricum administration might be useful rather than butyrate purgative in the management of
UC (Birt et al., 2013, p.601).
Vsl#3
This is a probiotic preparation containing four strains of lactobacilli (casei, plantarum,
bulgaricus, and acidophilus), three bifidobacteria strains (longum, infantis, and breve) as well as
Streptococcus thermophilus which are normal constituents of the human gut microflora.
6. 6
Management of this mix to IL-10 knockout pests reduce intestinal inflammation and TNF-α
secretion as well as interferon ((IFN)-γ from the mucosa and enhances the colonic barrier
purposes (Hold et al..2014. p.1192). It has been indicated to constrain Salmonella Dublin
invasion onto T-84 cells both in in vivo and in vitro and to change linoleic acid into the anti-
inflammatory conjugated linoleic acid (Kiyono et.,2016, p.621). Non-methylated genomic DNA
removed from VSL#3 hinders TNF-α-evoked IL-8 secretions, mitogen-activated protein kinases
activations as well as NF-κBinitiation in HT-29 cells in HT-29 cell, and weakens intestinal
irritation in murine models of colitis via the TLR-9 receptors (Laval et al., p.9). This mix has
currently demonstrated roles in potentiating mucin countenance in investigational models (Birt et
al., 2013, p.601). Nevertheless, in a pest DSS colitis model the change of microflora by
supplementation with the VSL#3 didn’t repair the colonic barricade failure and didn’t heal
chronic DSS-evoked colitis (Kashyap et al., 2013, p.977).
The Microflora
The fetal intuitive is germ-free, and colonization with microbes is unrelenting contact
between the child along with its environment, depending on the delivery mode, levels of
hygiene, medication and feeding type, since differences with gut microflora conformation
happen between formula-fed infants and breast (Capitán‐ Cañadas et al., 1110). The microbial
load of the bowel comprises of “naïve” species which permanently colonize the intestine
(impartially steadied until the 4th year of life) and fleeting bacteria which are unceasingly
ingested from the peripheral milieu. Microorganisms play an enormously significant role in the
development of the gut immune systems, since it has been established in animals bred in germ-
free settings that exhibit vault hyperplasia, lack of lymphoid follicle developments as well as
other structural vagaries (Capitán‐ Cañadas et al., 1110).
Microbiological cultures in the beginning, and then nucleic acid-based techniques
“[polymerase chain reaction, 16S rRNA probing, fluorescence in situ hybridization (FISH)]”
were applied to explicate the microbial constituents of the intestinal lumens. Gastric acid,
pancreatic and bile secretions result in diminished colonization of the proximal small intestine by
most microorganisms, however density of bacteria increases in the large bowel and distal small
intestine. The faecaes and stuffing of the large bowel encompass about 1011−1012 microbial cells
for each gram of wet mass, while microorganisms from about 55-61% of the faecal weight. This
luminal bacteriological populace composes the faecal microbiota. In healthy individuals, for
phyla (Proteobacteria, Actinobacteria, Firmicutes, and Bacteroeidetes,) as well as three groups
(Bacteroides-Prevotella group, C. leptum subgroup and Bacteroeidetes), all comprising several
species and genera) are present inside faeces. There are similarly Archaea and Fungi, however
these encompass a very small proportion of the entire quantity. Aside from the faecal microbotia,
other educations have been implemented to elucidate the individuality of microorganism present
on the mucosal superficial, signifying that they characterize a different populace that is in direct
contact with the mucosal immune system and intestinal cells of the guts. This bacterial populace
comprises of the mucosal microbiota. The aforementioned concern the microbes concern the
microorganisms, as well as other studies have clarified the microorganisms present on the
mucosal surface (Hold et al..2014. p.1192).
It has been experimented that nearly 50% of microorganisms traced with molecular
techniques couldn’t be cultured within the lab using standard systems. This discloses the
problems met in trying to classify each microorganisms making up the microflora. The mucus
7. 7
presence that is of great significance in the nesting of the commensal vegetation has to be
considered in the course of ascertaining microorganisms. As was pointed out by Tannock, DNA-
based methods expose only who could have been present. Additionally, RNA-based methods
identify microorganisms which are metabolically vigorous at the experimentation time.
Consequently, the usage of the function-exposing methods such as proteomics and
transcriptomics is essential so as to reveal the exact microflora’s role (Hold et al..2014. p.1192).
In addition, it has been proposed that, apart from distinguishing the presence of a definite species
of microbes, it is essential to distinguish its scrupulous position in the substructure of the
microflora, hence making known the word ‘spatial organization of the mucosal flora’
The roles of Microflora in Inflammatory Bowel Disease
Experimental and clinical evidences have led to the supposition that microbes generally
and commensal microflora more exactly play a significant role in the perpetuation and onset of
Inflammatory Bowel Disease. In 1985 Harper showed that reinstating the small bowel sewage of
the patient with CD managed with riven colostomy, instead of its germ-free ultra-filtrate (which
contain non microbial cells or other inordinate particles), into the “hibernating” colon made
inflammation of the region. Additionally, alteration of the stream within CD lessens gut
inflammation and triggers healing within the debarred part of the bowel, while pouchits doesn’t
happen afore ileostomy takedown. Another remark that stalwartly supports this philosophy is the
prevalence of Inflammatory Bowel Disease abrasions in regions of the greatest microbial
exposure, this is incurable ileum, ileal and colon purses. Antibiotics have been confirmed of
some worth in managing IBD although there is proof of action instead of decently antimicrobial,
as validated by experimental model of the ciprofloxacin and inflammation (Moreno et al., 2014,
p.187).
The role of microorganisms in Inflammatory Bowel Disease is strongly validated by
sterile animal experimentations. Genetically engineered (gene knock-out and transgenic) pests
display deadly intestinal irritation under standard lab conditions, however failed to do so when
raised in a sterile milieu and chemically induced colitis with (TNBS); trinitrobenzene sulphonic
acid happens in normal pests, however not in rats formerly treated with antibiotic. Furthermore,
adding diverse species of microbes or diverse LPS parts from the similar strain in transgenic
animals comprises diverse lymphocytes subpopulation initiation. The findings suggest that not
every microorganism triggers the similar antigenic stimulation that means that management with
probiotic strains primarily depends on the chosen strain (Huttenhower, Kostic, and Xavier, 2014,
p. 854).
The faecal and mucosal microbiota has been found to vary between fit subjects and
patients Inflammatory Bowel Disease. Even though fallouts are differing about the overriding
species in every case (Owaga et al., 2015, p. 20858), one might say that there are distinctive
characteristics which distinguish the microbiota inhabiting the tract of patient with IBD in
contrast with that of health individuals (Huttenhower, Kostic, and Xavier, 2014, p. 854). There is
greater biodiversity of species in fit subjects, as well as overriding species include nearly ninety-
percent of the entire microbial populace, while in IBD patient, biodiversity is lower and there’s
great proportion (nearly 30%) of “unusual species.” It has similarly been shown that healthy
people are pigeonholed by a greater Firmicutes percentage (Nami, Haghshenas, and Yari
Khosroushahi, 2017, p.563)
Roles of Prebiotics
8. 8
These are complex carbohydrates that stimulate the development of specific species of the
microflora of the host leading to bettered enteric purpose (Salazar et al., 2016, p.1440). These
complex food elements primarily act by increasing the populace of definite microbes and hence
quantitatively changing the microflora. As soon as they reach the colon, they are fermented by
anaerobic microbes, producing short-chain fatty acids along with the gas (Carbon-dioxide and
water). In the effect, intraluminal pH drips, favoring the rise of nonpathogenic E. coli,
Lactobacilli and Bifidobacteria as well as reducing Bifidobacteria. The fermentation of
C12H12O11 similarly leads to the production of butyrate, propionic and acetic acids, which are
involved in numerous colon-specific as well as systematic paths (Shetty et al., 2017, p.199).
Acetate is utilized as cell fuel and propionic acid is included in cholesterol production. Of these,
butyrate is of great significance to the absorption of the colonocyte. It has similarly been
established that butyrate exerts anti-inflammatory action, by in vitro decreasing the countenance
of TNF-α-interrelated cytokines and upregulating IL-10 in pests, perhaps by reticence of the
nuclear NF-κB translocation (Minamoto et al., 2015, p.47). Butyrate purgatives have been
applied with feat in UC, however the need for incessant management confines its use. The most
frequently used prebiotics in investigational models and medical trials are insulin, oligofructose,
lactosucrose, lactulose, milk-oligosaccharides, germinated barley foodstuff, and psyllium
(Matijašić et al.,2016, p.578).
Lactulose
Lactulose weakens irritation in IL-10 knockout pests. It has similarly lessened
myeloperoxidase action, leukotriene B fabrication, TNF-α and upsurges Lactobacilli and
Bifidobacteria, when controlled for two weeks prior to stimulation of TNBS colitis in pests. It
has equally validated a dose-department valuable in DSS-evoked colitis. In an experimental
study, oral lactose had no valuable effects in patients of Inflammatory Bowel Disease as regards
experimental action, endoscopic score or immunohistochemical parameters, however improved
the life quality. Nonetheless, its side-effect majorly diarrhoea confines its use in medicinal trials
Lactosucrose
This is a water-soluble fibre that is displayed to upsurge the proportion of Bifidobacteria
as well as the entire amount of microorganisms healthy subjects, however with no impact on
SCFA. In a research by Teramoto, management of lactosucrose for two weeks in Inflammatory
Bowel Disease patients led to a rise in Bifidobacteria and a reduction in Bacteroidaceae, however
in spite of these favorable effects, lactosucrose hasn’t been further examined.
Oligofructose and inulin
These are both comprises of numerous saccharide units as well as have analogous
purposes in the bowel that motivate development and action of Bifidobacteria and Lactobacilli.
Their mixture averts increase of colitis in HLA-B27 transgenic pests. Inulin weakens irritation
and lessens marker of inflammation in DSS-evoked colitis, resulting also to the rise of lactic acid
microbes and drop in PH. Licht have testified that inulin and oligofructose feeding (distinctly) to
mice led to a grander proportion of lactic acid microorganisms and greater butyrate heights.
Oligofructose and Inulin given together, had analogous fallouts in heathy individuals. In a
medical experiment, patients with a deterioration of insignificant to moderate UC established
mesalazine in amalgamation with oligofructose-enhanced placebo or inulin. Oligofructose-
enhanced inulin is well allowed and linked with an early reduction in faecal calprotectin.
9. 9
Fructo- and milk-oligosaccharides
Fructo-oligosaccharides have been established to weaken TNBS-evoked colitis in mice,
encouraging the development of valuable lactic acid and increasing levels of butyrate, however
not DSS-colitis in pests. The mixture of inulin and fructo-oligosaccharides, uniting the beneficial
impact, the primary in the microflora modulation as well as of the succeeding in increasing levels
of butyrate, has been reported to weaken histological and macroscopic irritation in HLA-AB27
transgenic pests. Milk of the goat; oligosaccharides is fed to DSS-colitis pests had a useful effect
in preservation of their mass, with diminished colonic myeloperoxidase action, warmer scientific
symptoms as well as augmented MUC-3 likened with control and TNBS-colitis pests. In a
current study Vos had shown that nutritional supplementation of oligosaccharides enriched Th1-
dependent inoculation rejoinders in pests. In open label study by Lindsay in 15 CD patients,
fructo-oligosaccharides were publicized to raise IL-10 levels countenance within dendritic cell,
with a rise of Bifidobacteria (Zevin, McKinnon, Burgener, and Klatt, 2016, p.190)
Synbiotics
Symbiotic is combined products of pre-and probiotics. The aforementioned valuable
effects of both prebiotics and probiotics in investigational models and medical trials have
resulted to scientist to the thought of coalescing them in a novel healing scheme termed
synbiotic. As already shown (Martín et al., 2015, p.67), every prebiotic and probiotic has
distinctive features, acting in its individual way in moderating the microflora, and it’s hence
abstracted that there were several amalgamations to be studied. Furthermore, the multifaceted
association and purpose of the intestinal microflora doesn’t make sure that amalgamations that is
expected to action synergistically, founded on the fact that every constituent of the mix has a
detailed role, would do so. Nonetheless, it’s essential to study these management selections, as
the mix of managements will expectantly lead to suppler healing schemes, enhancing
acquiescence of patients and reducing costs (Shetty et al., 2017, p.199).
Treatment of Inflammatory Bowel Disease
Trivial inflammatory bowel disease
Management of trivial IBD requires topical management depending on the number of
symptoms. Less than three stools daily require a corticosteroid enema which is placed within the
rectum as a preservation enema to help reducing the symptoms. Further, a number of diverse
medications are recommended depending on symptoms such as antibiotics; used to manage
Crohn’s disease as well as its complications (abscesses and fistula), however are commonly not
applied in ulcerative colitis. Another prescription is Aminosalicylates which comprises of
olsalazine, mesalazine and sulfasalazine are used for moderate to mild crohn’s disease and any
ulcerative colitis. Glucocorticoids such as budesonide, prednisolone and hydrocortisone, are
used to cure and ulcerative colitis and Crohn's disease since their anti-inflammatory properties
act very rapidly to lessen symptoms
Conclusion
Throughout current decades, prebiotics and probiotics have been utilized an outsized
number of investigational models of clinical and colitis trials. Experimental studies in vivo and
in vitro have offered good proof that microbial and bacterial constituents are connected in the
pathogenic mechanism of gut pathophysiology along with that duodenal microflora plays an
essential role in the IBD pathogenesis. These studies have assisted in identifying the vicissitudes
10. 10
of the luminal setting and mucosal of bowel and to comprehend the interaction of these
microorganisms with the central mucosal immune systems within the gut. Nonetheless, a better
comprehension of this environment is required to find out which microbial strain or prebiotic
will be the idea management for a given bowel complaint. Conversely, experimental trials have
provided contradictory results hence far. It’s essential to cite the more philosophical medical
effect of this treatment in UC remissions and preventions of pouchitis within CD, while welfares
are restricted in CD fallouts must be collected as for nongastrointestinal signs of IBD.
pharmabiotics agents have shown lack of poisonousness when they appear to be an excellent
resolution to patients who were unenthusiastic to take medications (a very significant element,
particularly on situations such as IBD, where management is extended and hard to deal with),
prebiotics and probiotics are, not drugs but "nature products.’ Pre-and probiotics have proven
their valuable effect in healthy subjects, both clinically and experimentally, to an equivalent, in
our view a greater magnitude than in patients of IBD. The result from medical studies has shown
that these rehabilitations are equal to those conventionally used, besides, in a few cases, good at
maintaining remission induced by common remedies to examine their potential as preventive
means apart from IBD remedy.
11. 11
References
Berg, D., Clemente, J.C. and Colombel, J.F., 2015. Can inflammatory bowel disease be
permanently treated with short-term interventions on the microbiome?. Expert review of
gastroenterology & hepatology, 9(6), pp.781-795.
Birt, D.F., Boylston, T., Hendrich, S., Jane, J.L., Hollis, J., Li, L., McClelland, J., Moore, S.,
Phillips, G.J., Rowling, M. and Schalinske, K., 2013. Resistant starch: promise for
improving human health. Advances in Nutrition: An International Review Journal, 4(6),
pp.587-601.
Capitán‐ Cañadas, F., Ortega‐ González, M., Guadix, E., Zarzuelo, A., Suárez, M.D., Medina,
F.S. and Martínez‐ Augustin, O., 2014. Prebiotic oligosaccharides directly modulate
proinflammatory cytokine production in monocytes via activation of TLR4. Molecular
nutrition & food research, 58(5), pp.1098-1110.
Deriu, E., Liu, J.Z., Pezeshki, M., Edwards, R.A., Ochoa, R.J., Contreras, H., Libby, S.J., Fang,
F.C. and Raffatellu, M., 2013. Probiotic bacteria reduce salmonella typhimurium
intestinal colonization by competing for iron. Cell host & microbe, 14(1), pp.26-37.
Dupont, H.L., 2014. evidence for the role of gut microbiota in irritable bowel syndrome and its
potential influence on therapeutic targets. Alimentary pharmacology &
therapeutics, 39(10), pp.1033-1042.
Hold, G.L., Smith, M., Grange, C., Watt, E.R., El-Omar, E.M. and Mukhopadhya, I., 2014. Role
of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in
the past 10 years?. World journal of gastroenterology: WJG, 20(5), p.1192.
Huttenhower, C., Kostic, A.D. and Xavier, R.J., 2014. Inflammatory bowel disease as a model
for translating the microbiome. Immunity, 40(6), pp.843-854.
Jenkins, B.J., 2016. Multifaceted Role of IRAK-M in the Promotion of Colon Carcinogenesis via
Barrier Dysfunction and STAT3 Oncoprotein Stabilization in Tumors. Cancer cell, 29(5),
pp.615-617.
Kashyap, P.C., Marcobal, A., Ursell, L.K., Larauche, M., Duboc, H., Earle, K.A., Sonnenburg,
E.D., Ferreyra, J.A., Higginbottom, S.K., Million, M. and Tache, Y., 2013. Complex
interactions among diet, gastrointestinal transit, and gut microbiota in humanized
mice. Gastroenterology, 144(5), pp.967-977.
Kiyono, T., Wada, S., Ohta, R., Wada, E., Takagi, T., Naito, Y., Yoshikawa, T. and Sato, K.,
2016. Identification of pyroglutamyl peptides with anti-colitic activity in Japanese rice
wine, sake, by oral administration in a mouse model. Journal of Functional Foods, 27,
pp.612-621.
Konturek, P.C., Haziri, D., Brzozowski, T., Hess, T., Heyman, S., Kwiecien, S., Konturek, S.J.
and Koziel, J., 2015. Emerging role of fecal microbiota therapy in the treatment of
12. 12
gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol, 66(4), pp.483-
491.
Laval, L., Martin, R., Natividad, J.N., Chain, F., Miquel, S., De Maredsous, C.D., Capronnier, S.,
Sokol, H., Verdu, E.F., van Hylckama Vlieg, J.E.T. and Bermudez-Humaran, L.G., 2015.
Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium
prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-
permeability in mice. Gut microbes, 6(1), pp.1-9.
Leung, C., Rivera, L., Furness, J.B. and Angus, P.W., 2016. The role of the gut microbiota in
NAFLD. Nature Reviews Gastroenterology & Hepatology, 13(7), pp.412-425.
Martín, R., Miquel, S., Chain, F., Natividad, J.M., Jury, J., Lu, J., Sokol, H., Theodorou, V.,
Bercik, P., Verdu, E.F. and Langella, P., 2015. Faecalibacterium prausnitzii prevents
physiological damages in a chronic low-grade inflammation murine model. BMC
microbiology, 15(1), p.67.
Matijašić, M., Meštrović, T., Perić, M., Čipčić Paljetak, H., Panek, M., Vranešić Bender, D.,
Ljubas Kelečić, D., Krznarić, Ž. and Verbanac, D., 2016. Modulating composition and
metabolic activity of the gut microbiota in IBD patients. International journal of
molecular sciences, 17(4), p.578.
Minamoto, Y., Otoni, C.C., Steelman, S.M., Büyükleblebici, O., Steiner, J.M., Jergens, A.E. and
Suchodolski, J.S., 2015. Alteration of the fecal microbiota and serum metabolite profiles
in dogs with idiopathic inflammatory bowel disease. Gut microbes, 6(1), pp.33-47.
Moreno-Vilet, L., Garcia-Hernandez, M.H., Delgado-Portales, R.E., Corral-Fernandez, N.E.,
Cortez-Espinosa, N., Ruiz-Cabrera, M.A. and Portales-Perez, D.P., 2014. In vitro
assessment of agave fructans (Agave salmiana) as prebiotics and immune system
activators. International journal of biological macromolecules, 63, pp.181-187.
Nami, Y., Haghshenas, B. and Yari Khosroushahi, A., 2017. Effect of psyllium and gum Arabic
biopolymers on the survival rate and storage stability in yogurt of Enterococcus durans
IW3 encapsulated in alginate. Food science & nutrition, 5(3), pp.554-563.
Owaga, E., Hsieh, R.H., Mugendi, B., Masuku, S., Shih, C.K. and Chang, J.S., 2015. Th17 cells
as potential probiotic therapeutic targets in inflammatory bowel diseases. International
journal of molecular sciences, 16(9), pp.20841-20858.
Salazar, N., Gueimonde, M., de los Reyes-Gavilán, C.G. and Ruas-Madiedo, P., 2016.
Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermentable
substrates by the intestinal microbiota. Critical reviews in food science and
nutrition, 56(9), pp.1440-1453.
Shetty, S.A., Hugenholtz, F., Lahti, L., Smidt, H. and de Vos, W.M., 2017. Intestinal
microbiome landscaping: insight in community assemblage and implications for
microbial modulation strategies. Fems microbiology reviews, 41(2), pp.182-199.
Shida, K. and Nomoto, K., 2013. Probiotics as efficient immunopotentiators: translational role in
cancer prevention. The Indian journal of medical research, 138(5), p.808.
13. 13
Tabibian, J.H., O'hara, S.P., Trussoni, C.E., Tietz, P.S., Splinter, P.L., Mounajjed, T., Hagey,
L.R. and LaRusso, N.F., 2016. Absence of the intestinal microbiota exacerbates
hepatobiliary disease in a murine model of primary sclerosing
cholangitis. Hepatology, 63(1), pp.185-196.
Tiago, F.C.P., Porto, B.A.A., Ribeiro, N.S., Moreira, L.M.C., Arantes, R.M.E., Vieira, A.T.,
Teixeira, M.M., Generoso, S.V., Nascimento, V.N., Martins, F.S. and Nicoli, J.R., 2015.
Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of
inflammatory bowel disease. Beneficial microbes, 6(6), pp.807-815.
Trop, T.K., 2014. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel
disease. World journal of gastroenterology: WJG, 20(33), p.11505.
Tuncil, Y.E., Nakatsu, C.H., Kazem, A.E., Arioglu-Tuncil, S., Reuhs, B., Martens, E.C. and
Hamaker, B.R., 2017. Delayed utilization of some fast-fermenting soluble dietary fibers
by human gut microbiota when presented in a mixture. Journal of Functional Foods, 32,
pp.347-357.
Utrilla, M., Peinado, M., Ruiz, R., Rodriguez‐ Nogales, A., Algieri, F., Rodriguez‐ Cabezas, M.,
Clemente, A., Galvez, J. and Rubio, L.A., 2015. Pea (Pisum sativum L.) seed albumin
extracts show anti‐ inflammatory effect in the DSS model of mouse colitis. Molecular
nutrition & food research, 59(4), pp.807-819.
van Baarlen, P., Wells, J.M. and Kleerebezem, M., 2013. Regulation of intestinal homeostasis
and immunity with probiotic lactobacilli. Trends in immunology, 34(5), pp.208-215.
Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C.,
Carlsson, C.M., Asthana, S., Zetterberg, H., Blennow, K. and Bendlin, B.B., 2017. Gut
microbiome alterations in Alzheimer’s disease. Scientific Reports, 7(1), p.13537.
Zevin, A.S., McKinnon, L., Burgener, A. and Klatt, N.R., 2016. Microbial translocation and
microbiome dysbiosis in HIV-associated immune activation. Current opinion in HIV and
AIDS, 11(2), pp.182-190.